EPHA4 and amyotrophic lateral sclerosis: In a previous study, EphA4 expression was correlated with the prognosis of patients with amyotrophic lateral sclerosis (ALS), and blocking EphA4 with compound 1 increased the survival of ALS models in vivo [28].